← Leaderboards
Donna K. Arnett
University Of Minnesota Twin Cities
$55,551,217
Attributed
$55,551,217
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.8M · FY2005–18$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$55,551,217 · 10
By mechanism
R01$39,031,974 · 6
U01$14,928,381 · 2
P60$1,128,312 · 1
T32$462,550 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- David A Bernlohr$13,927,503
- Gianluigi Veglia$18,221,521
- Fung-Lung Chung$13,183,556
- Julia Steinberger$8,822,882
- Alan R. Sinaiko$5,509,300
Others in their field
Top investigators on “Genotype”
- David R. Weir · University Of Michigan At Ann Arbor$303,033,420
- Richard A Gibbs · Baylor College Of Medicine$211,329,145
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Stacey Gabriel · Massachusetts Institute Of Technology$153,486,482
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$141,132,078
Research focus
GenotypePhenotypeGenesProgramsHypertensionGeneticCandidate Disease GeneCohortParticipantVariantBaseClinical ResearchGenetic VariantMemberPharmaceutical PreparationsHuman SubjectResponseFamilyPersonsVariation (Genetics)StrokeFamily MemberDesignFamily Study
Grant awards (60)
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat$766,182
R01 · FY2018 · HL · contact PI
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat$706,804
R01 · FY2017 · HL · contact PI
HyperGEN: Genetics of Left Ventricular Hypertrophy$1,077,617
R01 · FY2016 · HL · contact PI
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat$671,437
R01 · FY2016 · HL · contact PI
HyperGEN: Genetics of Left Ventricular Hypertrophy$5,078,395
R01 · FY2015 · HL · contact PI
HyperGEN: Genetics of Left Ventricular Hypertrophy$1,514,338
R01 · FY2015 · HL · contact PI
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate$1,444,495
R01 · FY2015 · HL · contact PI
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat$787,756
R01 · FY2015 · HL · contact PI
HyperGEN: Genetics of Left Ventricular Hypertrophy$1,179,645
R01 · FY2014 · HL · contact PI
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate$924,356
R01 · FY2013 · HL · contact PI
HyperGEN: Genetics of Left Ventricular Hypertrophy$626,073
R01 · FY2013 · HL · contact PI
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate$1
R01 · FY2013 · HL · contact PI
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate$1,083,646
R01 · FY2012 · HL · contact PI
Genetic and Molecular Markers of Methotrexate Efficacy and Toxicity in Early...$245,420
P60 · FY2012 · AR · contact PI
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate$1,063,765
R01 · FY2011 · HL · contact PI
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat$586,337
R01 · FY2011 · HL · contact PI
Genetic and Molecular Markers of Methotrexate Efficacy and Toxicity in Early...$236,333
P60 · FY2011 · AR · contact PI
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate$992,004
R01 · FY2010 · HL · contact PI
Hypergen: Genetics of Left Ventricular Hypertrophy$783,557
R01 · FY2010 · HL · contact PI
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat$727,323
R01 · FY2010 · HL · contact PI
Genetic and Molecular Markers of Methotrexate Efficacy and Toxicity in Early...$225,146
P60 · FY2010 · AR · contact PI
Hypergen: Genetics of Left Ventricular Hypertrophy$773,784
R01 · FY2009 · HL · contact PI
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat$757,424
R01 · FY2009 · HL · contact PI
Genetics of Hypertension Associated Treatment (GENHAT)$253,750
R01 · FY2009 · HL · contact PI
Genetic and Molecular Markers of Methotrexate Efficacy and Toxicity in Early...$167,454
P60 · FY2009 · AR · contact PI
Hypergen: Genetics of Left Ventricular Hypertrophy$1,276,399
R01 · FY2008 · HL · contact PI
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat$793,189
R01 · FY2008 · HL · contact PI
Genetic and Environmental Determinants of Triglycerides$357,345
U01 · FY2008 · HL · contact PI
Genetic and Molecular Markers of Methotrexate Efficacy and Toxicity in Early...$253,959
P60 · FY2008 · AR · contact PI
Genetics of Hypertension Associated Treatment (GENHAT)$253,750
R01 · FY2008 · HL · contact PI
Hypergen: Genetics of Left Ventricular Hypertrophy$1,216,551
R01 · FY2007 · HL · contact PI
Genetic and Environmental Determinants of Triglycerides$350,299
U01 · FY2007 · HL · contact PI
Genetics of Hypertension Associated Treatment (GENHAT)$326,250
R01 · FY2007 · HL · contact PI
Hypergen: Genetics of Left Ventricular Hypertrophy$1,251,494
R01 · FY2006 · HL · contact PI
Genetic and Environmental Determinants of Triglycerides$2,180,086
U01 · FY2005 · HL
Genetic and Environmental Determinants of Triglycerides$3,013,681
U01 · FY2004 · HL
HYPERGEN: GENETICS OF LEFT VENTRICULAR HYPERTROPHY$280,546
R01 · FY2004 · HL
MESA Family Study$31,500
R01 · FY2004 · HL
Genetic and Environmental Determinants of Triglycerides$3,361,710
U01 · FY2003 · HL
GENHAT-GENETICS OF HYPERTENSION ASSOCIATED TREATMENTS$999,971
R01 · FY2003 · HL
NHLBI FAMILY BLOOD PRESSURE PROGRAM-HYPERGEN-MPLS FC$647,358
U01 · FY2003 · HL
HYPERGEN: GENETICS OF LEFT VENTRICULAR HYPERTROPHY$462,136
R01 · FY2003 · HL
Genetic and Environmental Determinants of Triglycerides$254,461
U01 · FY2003 · HL
TRAINING GRANT IN CVD GENETIC EPIDEMIOLOGY$164,967
T32 · FY2003 · HL
MESA Family Study$148,060
R01 · FY2003 · HL
Genetic and Environmental Determinants of Triglycerides$2,337,955
U01 · FY2002 · HL
COMMUNITY SURVEILLANCE OF CARDIOVASCULAR DISEASE--RISK F$1,769,325
R01 · FY2002 · HL
GENHAT-GENETICS OF HYPERTENSION ASSOCIATED TREATMENTS$1,216,653
R01 · FY2002 · HL
NHLBI FAMILY BLOOD PRESSURE PROGRAM-HYPERGEN-MPLS FC$850,534
U01 · FY2002 · HL
HYPERGEN: GENETICS OF LEFT VENTRICULAR HYPERTROPHY$792,804
R01 · FY2002 · HL
TRAINING GRANT IN CVD GENETIC EPIDEMIOLOGY$155,039
T32 · FY2002 · HL
COMMUNITY SURVEILLANCE OF CARDIOVASCULAR DISEASE--RISK F$1,782,529
R01 · FY2001 · HL
GENHAT-GENETICS OF HYPERTENSION ASSOCIATED TREATMENTS$1,132,667
R01 · FY2001 · HL
NHLBI FAMILY BLOOD PRESSURE PROGRAM-HYPERGEN-MPLS FC$908,122
U01 · FY2001 · HL
HYPERGEN: GENETICS OF LEFT VENTRICULAR HYPERTROPHY$833,998
R01 · FY2001 · HL
TRAINING GRANT IN CVD GENETIC EPIDEMIOLOGY$142,544
T32 · FY2001 · HL
HYPERGEN: GENETICS OF LEFT VENTRICULAR HYPERTROPHY$1,000,207
R01 · FY2000 · HL
GENHAT$954,906
R01 · FY2000 · HL
COMMUNITY SURVEILLANCE OF CARDIOVASCULAR DISEASE--RISK F$710,350
R01 · FY2000 · HL
NHLBI FAMILY BLOOD PRESSURE PROGRAM-HYPERGEN-MPLS FC$666,830
U01 · FY2000 · HL